best pharmaceutical companies for CNS disorders
AI Search Visibility Analysis
Analyze how brands appear across multiple AI search platforms for a specific prompt
Total Mentions
Total number of times a brand appears
across all AI platforms for this prompt
Platform Presence
Number of AI platforms where the brand
was mentioned for this prompt
Linkbacks
Number of times brand website was
linked in AI responses
Sentiment
Overall emotional tone when brand is
mentioned (Positive/Neutral/Negative)
Brand Performance Across AI Platforms
| BRAND | TOTAL MENTIONS | PLATFORM PRESENCE | LINKBACKS | SENTIMENT | SCORE |
|---|---|---|---|---|---|
1Johnson & Johnson | 4 | 2 | 95 | ||
2Pfizer | 4 | 1 | 72 | ||
3Bristol Myers Squibb | 5 | 0 | 71 | ||
4Biogen | 4 | 0 | 70 | ||
5Novartis | 4 | 0 | 70 | ||
6Lundbeck | 2 | 1 | 62 | ||
7Alto Neuroscience | 2 | 0 | 59 | ||
8UCB | 1 | 1 | 59 | ||
9AbbVie | 1 | 0 | 56 | ||
10Neumora Therapeutics | 1 | 0 | 56 | ||
11CNS Pharmaceuticals | 1 | 0 | 56 | ||
12Axsome Therapeutics | 1 | 0 | 55 |
Strategic Insights & Recommendations
Dominant Brand
Biogen emerges as the most consistently recommended brand across platforms, recognized for over 40 years of neuroscience leadership and comprehensive CNS disorder treatments.
Platform Gap
ChatGPT focuses on established pharmaceutical giants with specific drug portfolios, while Google AIO and Perplexity emphasize emerging biotech companies and innovative treatment approaches like precision medicine and psychedelics.
Link Opportunity
Companies like Alto Neuroscience, Neumora Therapeutics, and CNS Pharmaceuticals represent emerging opportunities for partnerships and investment in specialized CNS treatment development.
Key Takeaways for This Prompt
Biogen leads the CNS pharmaceutical space with four decades of neurological disease treatment experience.
Major pharmaceutical companies are expanding CNS portfolios through strategic acquisitions of specialized biotech firms.
Emerging companies are focusing on precision medicine and novel approaches like psychedelics for CNS disorders.
The CNS drug development field faces significant scientific and financial challenges but addresses substantial unmet medical needs.
AI Search Engine Responses
Compare how different AI search engines respond to this query
ChatGPT
BRAND (4)
SUMMARY
ChatGPT highlights four major pharmaceutical companies excelling in CNS disorders: Johnson & Johnson (through Janssen Pharmaceuticals) focusing on schizophrenia, depression, and Alzheimer's; Pfizer with treatments for Alzheimer's, depression, and epilepsy; H. Lundbeck specializing in brain diseases including depression, schizophrenia, and Parkinson's; and Novartis developing treatments for multiple sclerosis and Parkinson's disease. All companies demonstrate strong R&D commitment in neurological treatments.
Perplexity
BRAND (9)
SUMMARY
Perplexity provides a comprehensive overview of CNS pharmaceutical leaders, emphasizing Biogen's 40+ years of neurological expertise, Neumora Therapeutics' precision medicine approach, and major players like Johnson & Johnson, AbbVie, Pfizer, and Bristol Myers Squibb expanding through strategic acquisitions. The response also highlights emerging companies like CNS Pharmaceuticals, Axsome Therapeutics, and UCB, noting the field's high scientific and financial challenges while addressing substantial unmet medical needs.
REFERENCES (8)
Google AIO
BRAND (5)
SUMMARY
Google AIO categorizes CNS pharmaceutical companies into established leaders (Biogen, Johnson & Johnson, Novartis, Bristol Myers Squibb) with broad portfolios, specialized companies (Alto Neuroscience, Psylo, Reunion Neuroscience, Gilgamesh) focusing on specific approaches like personalized treatments and psychedelics, and emerging biotech firms (Immunic Therapeutics, Kyverna Therapeutics, Progentos Therapeutics) advancing innovative CNS therapies across multiple neurological conditions.
REFERENCES (7)
Share Report
Share this AI visibility analysis report with others through social media